Although we did not compare the CK-19 RGE with the number of immunostained tumour cells in bone marrow cytospins in this study, the Taqman quantitative real-time RT–PCR methodology has been validated by us in a group of patients with metastatic breast cancer [24]. This evidence concerns the gene KRT19 and neoplasm.